About Isabella Loosle

ALS Crowd Contributor and student of neurodegenerative disorders.

What is bALS?

When categorizing ALS, there are two categories that most people use: familial and sporadic. Although this is one way to categorize the disease, there are many other ways to do so. ALS can also be classified by what part of the body the disease first appears. ALS symptoms can either first seen in the arms [...]

Read More

FDA Approves APB-102 as an Orphan Drug for Familial ALS Patients

The FDA recently granted the status of 'orphan drug' to APB-102, a potential gene therapy for familial ALS. Orphan drug status is given to terminal diseases that affect small numbers of patients.  John Reilly, Chief Executive Officer and co-founder of Apic Bio says they plan to open a clinical trial for APB-102. This trial will [...]

Read More

Gut Microbes May be Linked to ALS Progression

A recent study published in Nature may give ALS patients some insight into how gut microbes affect the progression of ALS.  What are microbes? Inside every person is a microbiome, a community of microorganisms that are also known as microbes. Microbes inhabit a person skin, mucosa, and gastrointestinal tract, but also live in plants, animals, [...]

Read More

Different Types of Helpful Physical Therapy for ALS Patients

Despite there being no cure for ALS, there are a variety of treatment options for those affected by the disease. One of these being physical therapy. Physical therapy is one of many treatments that can help reduce pain and instill a feeling of independence in ALS patients. Why physical therapy? Physical therapy is very beneficial [...]

Read More

Join Us! ALS Crowd Builds Patient and Family/Caregiver Facebook Groups for Online Support

Every year roughly 5,600 people are diagnosed with ALS, a rare and progressive neurodegenerative disease. Because ALS is a terminal disease, it is critical that patients and caregivers share as much information as possible with their peers. ALS Crowd invites you to join our patient and caregiver groups. We will be providing weekly information [...]

Read More